Noronha, Vanita
Sekar, Anbarasan
Rajendra, Akhil
Mokal, Smruti
Patil, Vijay
Menon, Nandini
Chopade, Sunil
Singh, Ajay Kumar
Kaushal, Rajiv Kumar
Mahajan, Abhishek
Janu, Amit
Purandare, Nilendu
Dikshit, Rajesh
Banavali, Shripad
Prabhash, Kumar
Badwe, Rajendra
Article History
Accepted: 13 November 2022
First Online: 23 November 2022
Declarations
:
: The study was performed in line with the principles of the Declaration of Helsinki. Deidentified clinicodemographic details were analyzed, hence ethical clearance was not sought.
: <i>Vanita Noronha</i> (all payments made to the institution). Research Funding: Sanofi/Aventis, Dr. Reddy's Laboratories, Intas, AstraZeneca. Travel, Accommodations, Expenses: American Society of Clinical Oncology. <i>Vijay Patil</i> (all payments made to the institution). Research Funding: Johnson & Johnson/Janssen, AstraZeneca, Intas, NATCO Pharma, Eisai Germany, Novartis. <i>Kumar Prabhash</i> (all payments made to the institution). Research Funding: Biocon, Dr Reddy's Laboratories, Fresenius Kabi, AIkem Laboratories, NATCO Pharma, BDR Pharmaceutics, Roche. No other potential conflicts of interest were reported.